Franklin LibertyQ U.S. Small Cap Equity ETF
FLQS - ETF AI Analysis
Top Page
Franklin LibertyQ U.S. Small Cap Equity ETF (FLQS)
FLQS, the Franklin LibertyQ U.S. Small Cap Equity ETF, has a solid overall rating driven mainly by strong, profitable holdings like Alkermes, Qualys, and CareTrust REIT, which show good growth prospects and sound financials. The presence of more mixed names such as CommVault Systems and The Cheesecake Factory, where higher leverage, bearish technical trends, or valuation concerns appear, slightly weighs on the fund’s quality. A key risk factor is its focus on smaller U.S. companies, which can be more volatile and sensitive to market swings than large-cap stocks.
FLQS vs. SPDR S&P 500 ETF (SPY)
- AUM
- 49.04M
- Region
- North America
- Expense Ratio
- 0.35%
- Beta
- 0.73
- Issuer
- Franklin
- Inception Date
- Apr 26, 2017
- Dividend Yield
- 1.49%
- Asset Class
- Equity
- Index Tracked
- LibertyQ US Small Cap Equity
FLQS Summary
Franklin LibertyQ U.S. Small Cap Equity ETF (FLQS) is a fund that follows the LibertyQ US Small Cap Equity index, focusing on smaller U.S. companies with room to grow. It spreads your money across many sectors, including technology, consumer, financial, and health care stocks, with holdings like Abercrombie & Fitch and Cheesecake Factory. Investors might consider FLQS to tap into the long-term growth potential of small companies while getting broad diversification beyond the big, well-known large caps. A key risk is that small-cap stocks can be more volatile, so the ETF’s value can move up and down sharply with the market.
How much will it cost me?
This ETF has an expense ratio of 0.35%, which means you’ll pay about $3.50 per year for every $1,000 invested. That’s a bit higher than the cheapest index ETFs because it uses a smart beta, actively designed strategy to pick small-cap stocks based on factors like quality, value, momentum, and low volatility.
What would affect this ETF?
This ETF could benefit if the U.S. economy stays healthy, as small companies in areas like technology, consumer spending, and financials often grow faster when business activity, innovation, and consumer confidence are strong. On the other hand, it could be hurt by higher interest rates, an economic slowdown that hits small U.S. firms and retailers, or tighter regulations affecting banks, health care, and tech companies in its top holdings.
FLQS Top 10 Holdings
FLQS leans into U.S. small caps with a mix of tech, consumer, and health names driving the story. Cybersecurity player Qualys and retailer Abercrombie & Fitch have been rising, giving the fund a helpful tailwind, while CommVault’s mixed momentum and Moog’s recent slide act as small speed bumps. Biotech names like Alkermes and Protagonist Therapeutics add a more volatile, but generally upbeat, edge. With all holdings U.S.-based and no single stock dominating, performance is shaped by broad small-cap strength rather than one star player.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Abercrombie Fitch | 1.07% | $524.06K | $6.32B | 107.87% | 78Outperform | |
| Alkermes | 1.04% | $510.75K | $7.90B | 51.66% | 80Outperform | |
| CommVault Systems | 0.94% | $462.29K | $6.22B | 20.10% | 65Neutral | |
| Essent Group | 0.97% | $477.89K | $5.68B | 5.52% | 73Outperform | |
| Protagonist Therapeutics | 0.89% | $437.37K | $8.55B | 57.32% | 68Neutral | |
| Qualys | 0.91% | $446.19K | $6.04B | 20.67% | 78Outperform | |
| Selective Insurance Group | 0.90% | $441.48K | $6.06B | 29.21% | 77Outperform | |
| Moog | 0.89% | $434.57K | $10.76B | 69.21% | 73Outperform | |
| CareTrust REIT | 0.87% | $427.15K | $9.81B | 6.52% | 80Outperform | |
| Cheesecake Factory | 0.89% | $438.62K | $5.44B | 137.76% | 66Neutral |
FLQS Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FLQS, the sentiment is Positive. The current price of 49.08 is above the 20-day moving average (MA) of 48.98, above the 50-day MA of 48.19, and above the 200-day MA of 46.73, indicating a bullish trend. The MACD of 0.28 indicates Positive momentum. The RSI at 52.71 is Neutral, neither overbought nor oversold. The STOCH value of 42.20 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FLQS.
FLQS Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $49.08 | $53.00(7.99% Upside) | $49.04M | 0.35% | 69Neutral | |
| $36.71 | $49.82(35.70% Upside) | $84.23M | 0.64% | 64Neutral | |
| $43.05 | $52.90(22.88% Upside) | $83.32M | 0.04% | 65Neutral | |
| $26.69 | $33.96(27.24% Upside) | $82.55M | 0.75% | 65Neutral | |
| $36.88 | $45.59(23.60% Upside) | $78.22M | 0.18% | 65Neutral | |
| $29.03 | $36.61(26.13% Upside) | $60.09M | 0.61% | 66Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| FLQS | Franklin LibertyQ U.S. Small Cap Equity ETF | 49.08 | 8.54 | 21.08% | |
| RUSC | US Small Cap Equity Active ETF | 36.71 | 7.51 | 25.71% | |
| BKSE | BNY Mellon US Small Cap Core Equity ETF | 43.05 | 8.08 | 23.10% | |
| AIMS | Acuitas Small Cap Active ETF | 26.68 | 1.50 | 5.98% | |
| STXK | Strive 2000 ETF | 36.88 | 5.65 | 18.11% | |
| SYZ | Lazard US Systematic Small Cap Equity ETF | 29.02 | 5.48 | 23.30% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
